GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...
These latest developments come just a few weeks after DeepSeek's release of a lower-cost AI model rattled markets, as it sparked concerns about the level of spending by major US tech companies in this ...
Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...
Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.
Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...
MaxiVision, the south India’s eye care hospital chain led by industry veteran GSK Velu, is now eyeing expansion in western ...
The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
The class action concerns whether GSK and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. Continue reading your article with a WSJ ...
These drugs also include five from AstraZeneca, three from Pfizer Products India Pvt. and one from GSK Pharmaceuticals. Following the announcement, shares of AstraZeneca rose as much as 4.28% to Rs ...
If making a budget seems daunting, you're not alone. That's why many apps do the grunt work for you. A good budgeting app can save you time and energy while helping you to spend smarter and save more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results